Announcements Trials
Browse Landscape

Phase

Phase NA 9Phase 2 8Phase 3 4Phase 1 4Phase 4 3Phase 1/2 2Phase EARLY_PHASE1 1

Status

Unknown 204Completed 93Recruiting 80Not yet recruiting 60Terminated 20Active not recruiting 10Withdrawn 8Enrolling by invitation 5Suspended 2

Sponsor Class

OTHER 850INDUSTRY 230NIH 54NETWORK 50OTHER_GOV 8

Study Type

Interventional 8

Sponsor

Cancer Type

Breast 4Gynecologic 1Gastrointestinal 1Dermatologic 1

Conditions

Breast Neoplasms 4Uterine Cervical Neoplasms 1Ulcer 1Stomatitis 1Neoplasm Metastasis 1Melanoma 1Colorectal Neoplasms 1

Interventions

genexol-PM 1Vinorelbine 1Paclitaxel 1Oxaliplatin 1Levoleucovorin 1Irinotecan 1Interleukin-2 1Immunotherapy 1Granulocyte-Macrophage Colony-Stimulating Factor 1Fluorouracil 1Disulfiram 1Curcumin 1Copper 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Phase 2 × Withdrawn × OTHER_GOV × Clear all
NCT06708702 2026-04-09

Copaíba-based Mouthwash in Oral Mucotitis Prevention and Treatment in Oral Cancer Patients During Radioteraphy

Instituto Nacional de Cancer, Brazil

Phase 2 Withdrawn

Stomatitis, Ulcer

NCT04199520 2024-03-04

Compare the Efficacy of Surgery Combined With Systemic Therapy and Pure Systemic Therapy in Breast Cancer Patients

Henan Cancer Hospital

Phase 2 Withdrawn
Breast

Breast Neoplasms

NCT04242329 2024-01-26

SUMMIST

Vastra Gotaland Region

Phase 2 Withdrawn
Dermatologic

Melanoma

NCT04265274 2023-10-06

Vinorelbine, Cisplatin, Disulfiram and Copper in CTC_EMT Positive Refractory Metastatic Breast Cancer.

National Cancer Institute, Slovakia

Phase 2 Withdrawn
Breast

Breast Neoplasms

NCT04294836 2022-12-07

Curcumin in Advanced Cervical Cancer

Instituto Nacional de Cancerologia, Columbia

Phase 2 Withdrawn
Gynecologic

Uterine Cervical Neoplasms

NCT04538833 2022-11-23

GM1 in the Treatment of Neurotoxicity Induced by Albumin-bound Paclitaxel

Henan Cancer Hospital

Phase 2 Withdrawn
Breast

Breast Neoplasms

NCT03222089 2018-03-27

Phase II Trial of FOLFOXIGIL Versus FOLFOXIRI as First-line Therapy in Patients With mCRC

Fujian Cancer Hospital

Phase 2 Withdrawn
Gastrointestinal

Colorectal Neoplasms

NCT01169870 2012-01-04

Genexol-PM Versus Paclitaxel in Anthracycline-pretreated Metastatic Breast Cancer Patients

National Cancer Center, Korea

Phase 2 Withdrawn
Breast

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡